Often on the way home from work I see many individuals on the train with their heads down – they are not sleeping; the majority of them are swiping their mobile device screen, searching for that one specific app they have downloaded to keep them occupied or entertained on their journey home. I have to admit that I too have a few go-to apps (yes, my list includes Angry Birds!) that help to pass the time as I head home and my list continues to grow, although lately I find myself asking – Do I really need this one? Continue reading
New eBook! Bennett & Brachman’s Hospital Infections
The latest, 6th edition of Bennett & Brachman’s Hospital Infections, is now available through MSK’s STAT!Ref library. This newest, full-color edition provides the most up-to-date information on all aspects of healthcare epidemiology and infection control. Bennett & Brachman’s Hospital Infections covers:
- The latest evidence-based strategies for the prevention of the big four HAIs—CLABSIs, CAUTIs, SSIs, and VAE.
- Prevention strategies through new coverage of automated room terminal disinfection (ultraviolet germicidal irradiation or hydrogen peroxide gas or vapor).
- New chapters on surgical site infection, dialysis, prevention of HAIs in intensive care units, mechanisms of resistance, the role of the environment in pathogen transmission, the role of the laboratory in infection prevention, prevalence vs. incidence HAI surveillance, infection prevention and control in countries with limited resources, the latest isolation procedures, and sterilization and disinfection.
- The latest evidence-based data on the control of antimicrobial-resistant pathogens, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, carbapenem-resistant enterobacteriaceae, and pandemic influenza viruses.
This resource can be accessed through STAT!Ref.
Burying the Hachette, Experimental Ebola Treaments on the Ground in West Africa and More…
Here are just a few of the items that caught my eye these past few weeks;
- Nature News reports that three experimental treatments for Ebola will be tested in Guinea beginning next month. The item links to an earlier Nature News piece about the ethical debate surrounding running trials during epidemics.